Markus Wieland

Markus Wieland is an accomplished professional with a strong educational background and extensive experience in the life sciences industry.

He holds a Master's degree in Life Science with outstanding academic achievements from the University of Konstanz and has also studied Biochemistry and Molecular Biology at Wesleyan University.

Markus completed his Bachelor's degree in Life Science with exceptional results at the University of Konstanz, showcasing his dedication to academic excellence.

With a wealth of experience in the field, Markus currently serves as the Director of Vaccine DS Manufacturing at Takeda, a prominent pharmaceutical company.

Prior to his current role, he held key positions at reputable organizations such as Sartorius Stedim Biotech, Boehringer Ingelheim, and Cellca GmbH, where he demonstrated his expertise and leadership skills.

Markus has contributed significantly to the industry, having served as the Head of Product Development - CMTS, Associate Director of Biopharmaceuticals Project Management, and Head of Operations at various stages of his career.

His professional journey includes roles such as Head of Process and Media Development at Cellca GmbH, Project Lead at Prolago Biotech, and Post-Doctoral Researcher at ETH Zurich.

His academic and professional background reflects a deep understanding of biochemistry, molecular biology, and biopharmaceuticals, positioning him as a valuable asset in the life sciences sector.